Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endovascular Treatment for Progressive Stroke Due to Vertebrobasilar Artery Occlusion
NCT07557485Not yet recruiting
- Sponsor
- FengGao
- Start
- Jun 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Randomised, single-blind trial in vertebrobasilar artery occlusion (VBAO) and ischemic stroke (2 arms), sponsored by FengGao. Primary endpoint: Proportion of patients achieving modified Rankin Scale score 0-3 at 90 days. Planned start Jun 2026; status: not yet recruiting.
02
Conditions
vertebrobasilar artery occlusion (VBAO)ischemic stroke
Beyond the preview
Go deeper on NCT07557485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07557485.